Exelixis
EXEL
#1649
Rank
A$16.10 B
Marketcap
$57.54
Share price
5.02%
Change (1 day)
81.99%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $76.90 AUD on 2000-07-26

Lowest end of day price: $2.01 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$57.21 0.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
$85.04 0.61%๐Ÿ‡ซ๐Ÿ‡ท France
$139.75 2.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$87.18 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$473.15 1.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$253.43 1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.07 1.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.84 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.42 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA